TY - JOUR
T1 - Impact of SARS-CoV-2 Infection on the Association Between Laboratory Tests and Severe Outcomes Among Hospitalized Children
AU - for the Pediatric Emergency Research Network-COVID-19 Study Team
AU - Xie, Jianling
AU - Kuppermann, Nathan
AU - Florin, Todd A.
AU - Tancredi, Daniel J.
AU - Funk, Anna L.
AU - Kim, Kelly
AU - Salvadori, Marina I.
AU - Yock-Corrales, Adriana
AU - Shah, Nipam P.
AU - Breslin, Kristen A.
AU - Chaudhari, Pradip P.
AU - Bergmann, Kelly R.
AU - Ahmad, Fahd A.
AU - Nebhrajani, Jasmine R.
AU - Mintegi, Santiago
AU - Gangoiti, Iker
AU - Plint, Amy C.
AU - Avva, Usha R.
AU - Gardiner, Michael A.
AU - Malley, Richard
AU - Finkelstein, Yaron
AU - Dalziel, Stuart R.
AU - Bhatt, Maala
AU - Kannikeswaran, Nirupama
AU - Caperell, Kerry
AU - Campos, Carmen
AU - Sabhaney, Vikram J.
AU - Chong, Shu Ling
AU - Lunoe, Maren M.
AU - Rogers, Alexander J.
AU - Becker, Sarah M.
AU - Borland, Meredith L.
AU - Sartori, Laura F.
AU - Pavlicich, Viviana
AU - Rino, Pedro B.
AU - Morrison, Andrea K.
AU - Neuman, Mark I.
AU - Poonai, Naveen
AU - Simon, Norma Jean E.
AU - Kam, April J.
AU - Kwok, Maria Y.
AU - Morris, Claudia R.
AU - Palumbo, Laura
AU - Ambroggio, Lilliam
AU - Navanandan, Nidhya
AU - Eckerle, Michelle
AU - Klassen, Terry P.
AU - Payne, Daniel C.
AU - Cherry, Jonathan C.
AU - Waseem, Muhammad
AU - Dixon, Andrew C.
AU - Ferre, Isabel Beneyto
AU - Freedman, Stephen B.
N1 - Publisher Copyright:
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
PY - 2023/10/1
Y1 - 2023/10/1
N2 - Background. To assist clinicians with identifying children at risk of severe outcomes, we assessed the association between laboratory findings and severe outcomes among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–infected children and determined if SARS-CoV-2 test result status modified the associations. Methods. We conducted a cross-sectional analysis of participants tested for SARS-CoV-2 infection in 41 pediatric emergency departments in 10 countries. Participants were hospitalized, had laboratory testing performed, and completed 14-day follow-up. The primary objective was to assess the associations between laboratory findings and severe outcomes. The secondary objective was to determine if the SARS-CoV-2 test result modified the associations. Results. We included 1817 participants; 522 (28.7%) SARS-CoV-2 test-positive and 1295 (71.3%) test-negative. Seventy-five (14.4%) test-positive and 174 (13.4%) test-negative children experienced severe outcomes. In regression analysis, we found that among SARS-CoV-2-positive children, procalcitonin ≥0.5 ng/mL (adjusted odds ratio [aOR], 9.14; 95% CI, 2.90–28.80), ferritin >500 ng/mL (aOR, 7.95; 95% CI, 1.89–33.44), D-dimer ≥1500 ng/mL (aOR, 4.57; 95% CI, 1.12–18.68), serum glucose ≥120 mg/dL (aOR, 2.01; 95% CI, 1.06–3.81), lymphocyte count <1.0 × 109/L (aOR, 3.21; 95% CI, 1.34–7.69), and platelet count <150 × 109/L (aOR, 2.82; 95% CI, 1.31–6.07) were associated with severe outcomes. Evaluation of the interaction term revealed that a positive SARS-CoV-2 result increased the associations with severe outcomes for elevated procalcitonin, C-reactive protein (CRP), D-dimer, and for reduced lymphocyte and platelet counts. Conclusions. Specific laboratory parameters are associated with severe outcomes in SARS-CoV-2-infected children, and elevated serum procalcitonin, CRP, and D-dimer and low absolute lymphocyte and platelet counts were more strongly associated with severe outcomes in children testing positive compared with those testing negative.
AB - Background. To assist clinicians with identifying children at risk of severe outcomes, we assessed the association between laboratory findings and severe outcomes among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–infected children and determined if SARS-CoV-2 test result status modified the associations. Methods. We conducted a cross-sectional analysis of participants tested for SARS-CoV-2 infection in 41 pediatric emergency departments in 10 countries. Participants were hospitalized, had laboratory testing performed, and completed 14-day follow-up. The primary objective was to assess the associations between laboratory findings and severe outcomes. The secondary objective was to determine if the SARS-CoV-2 test result modified the associations. Results. We included 1817 participants; 522 (28.7%) SARS-CoV-2 test-positive and 1295 (71.3%) test-negative. Seventy-five (14.4%) test-positive and 174 (13.4%) test-negative children experienced severe outcomes. In regression analysis, we found that among SARS-CoV-2-positive children, procalcitonin ≥0.5 ng/mL (adjusted odds ratio [aOR], 9.14; 95% CI, 2.90–28.80), ferritin >500 ng/mL (aOR, 7.95; 95% CI, 1.89–33.44), D-dimer ≥1500 ng/mL (aOR, 4.57; 95% CI, 1.12–18.68), serum glucose ≥120 mg/dL (aOR, 2.01; 95% CI, 1.06–3.81), lymphocyte count <1.0 × 109/L (aOR, 3.21; 95% CI, 1.34–7.69), and platelet count <150 × 109/L (aOR, 2.82; 95% CI, 1.31–6.07) were associated with severe outcomes. Evaluation of the interaction term revealed that a positive SARS-CoV-2 result increased the associations with severe outcomes for elevated procalcitonin, C-reactive protein (CRP), D-dimer, and for reduced lymphocyte and platelet counts. Conclusions. Specific laboratory parameters are associated with severe outcomes in SARS-CoV-2-infected children, and elevated serum procalcitonin, CRP, and D-dimer and low absolute lymphocyte and platelet counts were more strongly associated with severe outcomes in children testing positive compared with those testing negative.
KW - C-reactive protein
KW - COVID-19
KW - SARS-CoV-2
KW - child
KW - lymphopenia
KW - procalcitonin
UR - http://www.scopus.com/inward/record.url?scp=85176293480&partnerID=8YFLogxK
U2 - 10.1093/ofid/ofad485
DO - 10.1093/ofid/ofad485
M3 - Article
C2 - 37869403
AN - SCOPUS:85176293480
SN - 2328-8957
VL - 10
JO - Open Forum Infectious Diseases
JF - Open Forum Infectious Diseases
IS - 10
M1 - ofad485
ER -